23-valent Pneumococcal Polysaccharide Vaccine

23-valent  Pneumococcal Polysaccharide Vaccine
Product Description

To prevent invasive diseases caused by 23 serotypes of Streptococcus pneumoniae for use in individuals aged ≥ 2 years who are at increased risk of pneumococcal diseases

Yuxi Walvax Biotechnology Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Specifications
  • Details
    Single-dose per vial or pre-filled syringe, 0.5 mL/dose

Yuxi Walvax Biotechnology Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator

More Products from Yuxi Walvax Biotechnology Co., Ltd. (2)